NNBP — Nanobac Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $4.12m
- $0.02m
Annual balance sheet for Nanobac Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10KSB/A | 10KSB/A | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.05 | 0.018 | 0.009 | 0.04 | 0.004 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.006 | 0.003 | 0.003 | 0.001 | 0.002 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.087 | 0.116 | 0.174 | 0.127 | 0.031 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.137 | 0.126 | 0.108 | 0.061 | 0.038 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 8.25 | 9.69 | 8.97 | 7.83 | 7.22 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6.85 | 1.3 | 3.67 | 6.3 | 6.75 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.05 | 3.57 | 6.51 | 9.14 | 9.58 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.807 | 6.11 | 2.46 | -1.31 | -2.36 |
| Total Liabilities & Shareholders' Equity | 8.24 | 9.68 | 8.97 | 7.83 | 7.22 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |